First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Innovative Industrial Properties: the story is balanced — Tenant credit quality and lease coverage ratios - defaults or restructurings from major tenants like Kings Garden…
★ Analysts see FY2027 revenue reaching $288M — +5.7% growth in a single year.
What Moves the Stock
1Tenant credit quality and lease coverage ratios - defaults or restructurings from major tenants like Kings Garden, PharmaCann, or Parallel have driven significant volatility
2New acquisition volume and deployment of capital at accretive cap rates - pipeline visibility and transaction velocity
3Federal cannabis policy developments including SAFE Banking Act prospects, Schedule III reclassification progress, and state-level legalization momentum
4Interest rate environment affecting REIT valuations and IIPR's cost of capital for acquisitions
5Same-store rent growth from contractual escalators and lease renewal economics
6Base rental income from triple-net leases (approximately 85-90% of revenue)
7Percentage rent and lease escalators tied to tenant revenue or CPI adjustments (5-10%)
8Property management fees and reimbursements (3-5%)
value - The 0.7x price/book ratio, 20% FCF yield, and 7.4x EV/EBITDA indicate deep value territory…
Rising interest rates negatively impact IIPR through multiple channels: (1) REIT valuation compression as dividend yields become less…
Watch on earnings: 10-Year Treasury yield (GS10) - primary driver of REIT valuation multiples and cost of capital, High yield credit spreads (BAMLH0A0HYM2) - proxy for risk appetite and cannabis operator financing costs, Tenant-level lease coverage ratios and same-store NOI growth from quarterly supplements.
One Sentence Summary:
Innovative Industrial Properties: the story is balanced — tenant credit quality and lease coverage ratios - defaults or restructurings from major tenants like kings garden, pharmacann.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.